Expert panel underwhelmed by GSK's Promacta
This is a discussion on Expert panel underwhelmed by GSK's Promacta within the Biotechnology News forum, part of the Industry News and Updates category; An expert panel was underwhelmed by GlaxoSmithKline's data for Promacta, a treatment designed to decrease the frequency and severity ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-29-2008, 03:27 PM
|
|||
|
|||
Expert panel underwhelmed by GSK's Promacta
An expert panel was underwhelmed by GlaxoSmithKline's data for Promacta, a treatment designed to decrease the frequency and severity of bleeding episodes in people with thrombocytopenic purpura. The Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA approves GSK's Rotarix | industry_news | Biotechnology News | 0 | 04-04-2008 04:02 PM |
| U.S. FDA to Ask Panel About Anemia Drug Limits Reuters Health Information, March 12, | industry_news | Other Clinical Pharmacy News | 0 | 03-12-2008 01:05 PM |
| Panel: Overhaul Next Year's Flu Vaccine WebMD Health News, February 26, 2008 | industry_news | Other Clinical Pharmacy News | 0 | 02-26-2008 12:30 PM |
© 2008 DrugManagementForum™ powered by |
 |